Retraction Note: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer
This Article has been retracted; see accompanying Retraction Note. A previous correction is no longer appended to the PDF version of this paper but can be accessed here: https://doi.org/10.1038/ncomms10703 .
Saved in:
Main Authors: | D. M. Janzen, E. Tiourin, J. A. Salehi, D. Y. Paik, J. Lu, M. Pellegrini, S. Memarzadeh |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/eaa7a444cf554c8a89705e84e0b2a6d0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Corrigendum: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer
by: D. M. Janzen, et al.
Published: (2016) -
Retraction Note: Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy
by: V. La, et al.
Published: (2021) -
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
by: Hyoung Kim, et al.
Published: (2020) -
Retraction Note: The melanocortin signaling cAMP axis accelerates repair and reduces mutagenesis of platinum-induced DNA damage
by: Stuart G. Jarrett, et al.
Published: (2021) -
RETRACTION NOTE
by: Biryukova NA.
Published: (2017)